Literature DB >> 29750467

Chronic urticaria - What does the new guideline tell us?

Marcus Maurer1, Torsten Zuberbier1, Frank Siebenhaar1, Karoline Krause1.   

Abstract

Patients with chronic urticaria experience significant impairment, and require an effective treatment. Such treatment is preceded by a thorough diagnostic workup and measurement of disease activity, disease burden and disease control using well--established tools. Treatment is subsequently adjusted according to patient needs and therapeutic response, based on the tenet "as much as necessary, as little as possible" (in that order). Once disease control has been achieved, it is recommended that intermittent attempts at medication withdrawal be made in order to identify spontaneous disease remission. Chronic urticaria should be treated until spontaneous remission occurs.
© 2018 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29750467     DOI: 10.1111/ddg.13531

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  3 in total

1.  Thyroid Autoimmunity and Autoimmunity in Chronic Spontaneous Urticaria Linked to Disease Severity, Therapeutic Response, and Time to Remission in Patients with Chronic Spontaneous Urticaria.

Authors:  Kumutnart Chanprapaph; Wimolsiri Iamsumang; Penpun Wattanakrai; Vasanop Vachiramon
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

Review 2.  Chronic Urticaria: An Overview of Treatment and Recent Patents.

Authors:  Kam L Hon; Alexander K C Leung; Wing G G Ng; Steven K Loo
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2019

Review 3.  The safety and tolerability profile of bilastine for chronic urticaria in children.

Authors:  Nikolaos G Papadopoulos; Torsten Zuberbier
Journal:  Clin Transl Allergy       Date:  2019-10-23       Impact factor: 5.871

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.